Global Tuberculosis (TB) Diagnostics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Tuberculosis (TB) Diagnostics Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Tuberculosis (TB) is caused by a bacterium called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but TB bacteria can attack any part of the body such as the kidney, spine, and brain.
Several tests are used to diagnose tuberculosis (TB), depending on the type of TB suspected.

Market Overview:

The latest research study on the global Tuberculosis (TB) Diagnostics market finds that the global Tuberculosis (TB) Diagnostics market reached a value of USD 2561.68 million in 2022. It’s expected that the market will achieve USD 3359.68 million by 2028, exhibiting a CAGR of 4.62% during the forecast period.

Tuberculosis is one of the oldest infectious diseases in human history. Drug-resistant tuberculosis is even more difficult to treat in recent years, and the treatment time is as long as 18-24 months. If it eventually develops into extensively drug-resistant bacteria, it is almost impossible to completely cure and fight against tuberculosis for life.

WHO attaches great importance to the prevention and treatment of tuberculosis. The United Nations and WHO have convened several national-level conferences and developed the End TB Strategy, with specific targets for 2030: to reduce the absolute number of TB deaths by 90% compared with 2015, and the incidence of TB (annual the number of new cases per 100,000 population) decreased by 80%.

Therefore, with the high attention paid to the tuberculosis diagnosis and treatment market by countries around the world, the Tuberculosis (TB) Diagnostics Market has a good development prospect.

According to the consensus of WHO and tuberculosis stakeholders, the highest priorities for the development of tuberculosis diagnostic agents include:

Biomarker detection kit: a high-accuracy, non-invasive and sputum-free detection kit that can be used at diagnosis and treatment points. This kit should be able to identify characteristic biomarkers or biomarkers in all age groups and sub-populations, so as to detect all forms of tuberculosis (tuberculosis infection, drug-sensitive tuberculosis and drug-resistant tuberculosis) and determine who is more likely to develop tuberculosis after infection;

Shunt detection kit: a simple, low-cost detection kit that can be used at the diagnosis and treatment point, which can be used by the first-time health care service provider to determine who needs further detection;
Substitute smear detection kit: a more accurate (highly sensitive and specific) diagnostic detection kit that can be used in diagnosis and treatment points, which is used to replace smear microscopy for tuberculosis and monitor the treatment response of all subgroups and age groups;
Rapid drug sensitivity test kit: a kit that can be used at the level of microscope center in health care system, with the purpose of selecting appropriate first-line treatment scheme.

Political Factors

Political factors determine the degree of government's influence on the economy or an industry.

Market supervision and trade laws and regulations have also had a huge impact on the industry. And there will be more trade controls in north America and Europe. Through trade agreements and tariff policies, local enterprises have been protected to a certain extent.

The Chinese government attaches great importance to it, and has successively issued a series of policies, regulations and technical specifications, including the Plan of Action to Cure Tuberculosis (2019-2022), Technical Specifications for Tuberculosis Prevention and Control in China (2020 Edition) and Guidelines for Tuberculosis Prevention and Control in Chinese Schools (2020 Edition), etc.

Technological Factors

Strengthening research and innovation is one of the pillars of the strategy to eliminate tuberculosis epidemic. To achieve the goal of ending the epidemic of tuberculosis, we need diagnostic tools that can quickly diagnose tuberculosis and detect drug resistance, shorter course of treatment, safer and more effective preventive treatment of tuberculosis, treatment schemes of drug-sensitive tuberculosis and drug-resistant tuberculosis, more effective tuberculosis vaccine, and innovative strategies to solve the broader related factors of tuberculosis (such as poverty, malnutrition, HIV infection, smoking and diabetes, etc.).

Environmental Factors

For centuries, TB has been linked anecdotally with environmental risk factors that go hand-in-hand with poverty: indoor air pollution, tobacco smoke, malnutrition, overcrowded living conditions, and excessive alcohol use.
In countries with low incidence of tuberculosis, the probability of transmission to others may be very small, so there will be no outbreak of tuberculosis. However, in the low-income environment with heavy TB burden, the risk of TB infection is higher.

Region Overview:

Asia dominated the Tuberculosis (TB) Diagnostics market in 2021, with a market share of 50.27%.

Company Overview:

bioMérieux is one of the major players operating in the Tuberculosis (TB) Diagnostics market, holding a share of 11.41% in 2021.

bioMérieux

BioMerieux designs, develops, manufactures, and markets systems in the field of in vitro diagnostics for medical and industrial applications. The Company is specialized in the diagnosis of infectious diseases and pathologies. BioMerieux is also active in the analysis of food, pharmaceuticals and environmental samples to determine their microbiological quality.

F. Hoffmann-La Roche

Hoffmann-La Roche AG provides in-vitro diagnostics and drugs for cancer and transplantation. The Company specializes in medicines for oncology, virology, inflammation, metabolism, CNS, clinical chemistry, immunology, urinalysis, blood screening, genetics, infectious diseases, and microbiology.

Segmentation Overview:

As for product types, the Culture segment held the largest market share in 2021.

Smear Microscopy

Smear microscopy involves collecting a biological sample (usually sputum or some other clinical material), fixing it thinly on a glass slide and then staining it with a dye that binds specifically to mycobacteria (making them easier to identify under a microscope).

Molecular Testing

The majority of molecular tests have been focused on (i) detection of nucleic acids, both DNA and RNA, that are specific to Mycobacterium tuberculosis, by amplification techniques such as polymerase chain reaction (PCR); and (ii) detection of mutations in the genes that are associated with resistance to antituberculosis drugs by sequencing or nucleic acid hybridization.
The World Health Organization (WHO) has recommended the use of molecular nucleic acid amplification tests (NAATs) tests for TB detection instead of smear microscopy, as they are able to detect TB more accurately, particularly in patients with paucibacillary disease and in people living with HIV.

Mantoux Tuberculin Test

A Mantoux test is a skin test that is used to detect infection by Mycobacterium Tuberculosis (TB). It is used to determine any immune response in the skin, by any individual who could have been or is being exposed to the bacteria.

Culture

In the case of the TB culture test the test is to see if the TB bacteria Mycobacterium tuberculosis, are present. The substances are either solid substances on culture plates, or bottles of liquid known as culture broths. The substances are chosen to make it as easy as possible for the bacteria to grow.

Drug Susceptibility Testing

Drug susceptibility testing means testing to find out if a person has got drug resistant TB. That means finding out which drugs the TB bacteria in their body are sensitive to.

Application Overview:

The market's largest segment by application is the segment Hospitals, with a market share of 67.71% in 2021.

Diagnostic Laboratories

Diagnostic Laboratories work with medical practices to provide diagnostic services that provide medical professionals with information for proper diagnoses. Lab tests involve fluid samples, body scans, cell samples, and more.

Hospitals

A hospital is a health care institution providing patient treatment with specialized health science and auxiliary healthcare staff and medical equipment.

Key Companies in the global Tuberculosis (TB) Diagnostics market covered in Chapter 3:

BD
Qiagen
bioMérieux
Oxford Immunotec
Thermo Fisher Scientific
F. Hoffmann-La Roche
Danaher
Abbott
Hologic

In Chapter 4 and Chapter 14.2, on the basis of types, the Tuberculosis (TB) Diagnostics market from 2018 to 2029 is primarily split into:

Smear Microscopy
Molecular Testing
Mantoux Tuberculin Test
Culture
Drug Susceptibility Testing
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Tuberculosis (TB) Diagnostics market from 2018 to 2029 covers:

Diagnostic Laboratories
Hospitals
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)